A blog post by Paul Glasziou from January 2013 starts with this headline, which is very much in line with our thinking. 

Innovation is the cornerstone for progress in so many ways, but only the innovation that indeed proves to withstand rigorous testing will lead to lasting progress. Hence, evaluation should be seen as a tool to reach faster and more endurable progress rather than an unnecessary burden. This is the goal of our network, evaluating biomedical innovations in a mutual discourse and discussions on the way to be progress for patients.

To read Paul’s blog post, please follow THIS LINK.